These findings provide a platform for investigating the signaling pathways in HCC that are mediated by EVA1A and modulated by miR-103a-3p, offering new insights into the miRNA regulatory network in the development of HCC. This evidence concerns the gene EVA1A and hepatocellular carcinoma.